Home Page News Statistics API Review Formulation Monthly Im&Ex report All Information
     
Keyword:
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
　　Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Internationalization&nbs...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:www.healthoo.com >> EN >> Industry
Sinobiopharma got clinical approval of Eplerenone2010-08-11
China-made pill passed Phase II clinical trials in USA2010-08-10
4-methylMethcathinon controlled as psychotropic drug in China2010-08-06
Hisun plans raise 1.36 bln yuan to build production unit2010-08-03
First nationwide study on TCM to release in Nov2010-08-03
Charles River Labs calls off WuXi Pharmatech buy2010-08-02
Second Pharma seeks registration of Valsartan capsules in USA2010-07-30
New APIs production base started construction in Hubei2010-07-29
SFDA approves production of Ciclopirox Olamine vaginal suppositories2010-07-28
Leo Pharma to recall all batches of Sodium Fusidate in China2010-07-28
Merck collaborates with Sinopharm to boost China presence2010-07-28
Boehringer Ingelheim to expand stuff in China2010-07-27
A big unit of APIs under construction in Tianjin Jinghai2010-07-26
One more project of Nicotinic started construction2010-07-23
Capacity of Vitamin C project in Heihe is 10000 ton finally2010-07-21
National R&D center of large-Volume IV solutions under building in Chengdu2010-07-19
India to strengthen inspections on APIs from China2010-07-19
China issues rules to curb corruption in government drug purchases2010-07-16
27 websites nodded to sell medicine online by SFDA2010-07-14
MSD begins work on new unit in Hangzhou2010-07-13
Intelence (Etravirine) launched in China for HIV2010-07-07
Lee's Pharma wins sales right of Remodulin in China2010-07-06
2010 Chinese Pharmacopoeia promulgated2010-07-02
Pharmaceutical discharge standard of water pollutants implemented from today2010-07-01
Capacity of Vitamin B3 in China will increase sharply2010-06-30
The first Penicillin powder injection project started production in Hubei2010-06-28
China implements electronic monitoring for essential medicines2010-06-25
Medical cost of anti-syphilis to be refunded in China2010-06-24
United Laboratories to make routine overhaul2010-06-22
NDRC strengthens the check on the prices of basic drugs2010-06-21
Kun Run got approval to produce Entecavir2010-06-21
Domestic Entecavir approved in China2010-06-18
共1471个 页次:28/46页 32个/页 首页 上一页 下一页 尾页 转到：
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch，Fuwai Sub-Branch
④Address of bank:NO7，FUWAISTREET，XICHENG DISTRICT，BEIJING，CHINA SWIFT CODE：COMMCNSHBJG
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463